The real-world safety of sacubitril / valsartan among older adults (≥75): A pharmacovigilance study from the FDA data-Reference-Cited by-同舟云学术

The real-world safety of sacubitril / valsartan among older adults (≥75): A pharmacovigilance study from the FDA data

Published:2024-02 Issue: Volume:397 Page:131613
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Lerman Tsahi T.,Greenberg Noam,Fishman Boris,Goldman Adam,Talmor-Barkan Yeela,Bauer Menachem,Goldberg Idan,Goldberg Elad,Kornowski Ran,Krause Ilan,Levi Amos,Cohen Eytan

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference36 articles.

1. Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, randomized comparison of two uptitration regimens;Senni;Eur. J. Heart Fail.,2016

2. Sacubitril/valsartan in daily clinical practice: data from a prospective registry;Vicent;J. Cardiovasc. Pharmacol.,2019

3. Angiotensin–neprilysin inhibition versus enalapril in heart failure;McMurray;N. Engl. J. Med.,2014

4. Clinical Effectiveness of Sacubitril/Valsartan Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction;Greene;J. Am. Heart Assoc.,2021

5. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure;McDonagh;Eur. Heart J.,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use and Benefit of Sacubitril/Valsartan in Elderly Patients with Heart Failure with Reduced Ejection Fraction;Journal of Clinical Medicine;2024-08-14

2. A real-world disproportionality analysis of sacubitril/valsartan: data mining of the FDA adverse event reporting system;Frontiers in Pharmacology;2024-08-13

3. Real-life effectiveness of sacubitril/valsartan in older Belgians with heart failure, reduced ejection fraction and most severe symptoms;Scientific Reports;2024-06-12

4. Safety of sacubitril/valsartan among older adults. Where real world data meet clinical trials results;International Journal of Cardiology;2023-12